Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
10 NEW January 20, 2020
A virus for a therapeutic cancer vaccine

A virus for a therapeutic cancer vaccine

from the Pollack lab, Clinical Research Division
Science Spotlight - November 20, 2017
Teacher, mom — and living immunotherapy proof of principle

Teacher, mom — and living immunotherapy proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Hutch News - September 08, 2017
Understanding the tumor microenvironment for a better fight

Understanding the tumor microenvironment for a better fight

from the Pollack lab (Clinical Research Division)
Science Spotlight - June 19, 2017
Using a virus to teach the immune system to kill cancer

Using a virus to teach the immune system to kill cancer

‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Hutch News - June 02, 2017
First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy

First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy

Some types of sarcomas elicit a greater immune response than others, which sheds light on how immunotherapy could be used for this connective-tissue cancer, according to a new study in Cancer.
Releases - May 02, 2017
Deploying an ancient defense to kill cancer

Deploying an ancient defense to kill cancer

In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug
Hutch News - April 03, 2017
Last Modified, August 15, 2019